Tri Chemical Laboratories Inc (4369) Stock Price & News

4369:TYO

Tri Chemical Laboratories Inc

¥3,060.00

+0.16%

(+5.00) 1D

Sep 9, 3:30:00 PM GMT+9 · JPY

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Aug 31, 2026

Fiscal period

Q2 2027

EPS / Est. (JPY)

- / -

Revenue / Est. (JPY)

7.22B / 7.06B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in JPY

Loading Previous Earnings...

All values in JPY	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	5.64B	5.87B	7.49B	7.22B
Cost of goods sold	3.49B	3.71B	4.69B	4.69B
Cost of revenue	3.49B	3.71B	4.69B	4.69B
Research and development expenses	-	606.00M	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	758.51M	131.52M	730.52M	760.48M
Operating expense	758.51M	817.52M	730.52M	760.48M
Total operating expenses	4.25B	4.53B	5.42B	5.45B
Operating income	1.38B	1.34B	2.07B	1.77B
Other non operating income	-36.17M	-43.75M	-1.55M	85.49M
EBT including unusual items	1.66B	1.63B	2.49B	2.04B
EBT excluding unusual items	1.66B	1.63B	2.49B	2.04B
Income tax expense	413.68M	137.00M	630.03M	522.64M
Effective tax rate	24.94%	8.40%	25.35%	25.61%
Other operating expenses	-	-	-	-
Net income	1.24B	1.49B	1.86B	1.52B
Net profit margin	22.09%	25.43%	24.78%	21.04%
Earnings per share	-	-	-	-
Interest and investment income	6.48M	426.00K	3.83M	1.28M
Interest expense	-6.82M	-14.56M	-22.60M	-26.87M
Net interest expenses	-340.00K	-14.13M	-18.77M	-25.59M
Depreciation and amortization charges	-	80.00M	-	-
EBITDA	1.86B	1.92B	2.67B	2.38B
Gain or loss from assets sale	-	-	-	-

Finance